Literature DB >> 10681408

Contribution of the hepatic lipase gene to the atherogenic lipoprotein phenotype in familial combined hyperlipidemia.

H Allayee1, K M Dominguez, B E Aouizerat, R M Krauss, J I Rotter, J Lu, R M Cantor, T W de Bruin, A J Lusis.   

Abstract

Familial combined hyperlipidemia (FCH) is a common genetic lipid disorder with a frequency of 1-2% in the population. In addition to the hypercholesterolemia and/or hypertriglyceridemia that affected individuals exhibit, small, dense LDL particles and decreased HDL-cholesterol levels are traits frequently associated with FCH. Recently, we reported that families with FCH and families enriched for coronary artery disease (CAD) share genetic determinants for the atherogenic lipoprotein phenotype (ALP), a profile presenting with small, dense LDL particles, decreased HDL-cholesterol levels, and increased triglyceride levels. Other studies in normolipidemic populations have shown that the hepatic lipase (HL) gene is linked to HDL-cholesterol levels and that a polymorphism within the HL promoter (-514C-->T) is associated with increased HDL-cholesterol levels as well as larger, more buoyant LDL particles. In the present study, we tested whether the HL gene locus also contributes to ALP in a series of Dutch FCH families using nonparametric sibpair linkage analysis and association analysis. Evidence for linkage of LDL particle size (P < 0.019), HDL-cholesterol (P < 0.003), and triglyceride levels (P < 0.026) to the HL gene locus was observed. A genome scan in a subset of these families exhibited evidence for linkage of PPD (LOD = 2.2) and HDL-cholesterol levels (LOD = 1.2) to the HL gene locus as well. The -514C-->T promoter polymorphism was significantly associated (P < 0.0001) with higher HDL-cholesterol levels in the unrelated males of this population, but not in unrelated females. No association was observed between the polymorphism and LDL particle size or triglyceride levels. Our results provide support that ALP is a multigenic trait and suggest that the relationship between small, dense LDL particles, HDL-cholesterol, and triglyceride levels in FCH families is due, in part, to common genetic factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681408

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

Review 1.  Hepatic lipase: friend or foe and under what circumstances?

Authors:  Hans Jansen
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

Review 2.  The genetics of familial combined hyperlipidaemia.

Authors:  Martijn C G J Brouwers; Marleen M J van Greevenbroek; Coen D A Stehouwer; Jacqueline de Graaf; Anton F H Stalenhoef
Journal:  Nat Rev Endocrinol       Date:  2012-02-14       Impact factor: 43.330

3.  Familial combined hyperlipidemia in a North Indian kindred.

Authors:  C S Sriram; Sheffali Gulati; Vikas Chopra; Suman Vashist; P S N Menon
Journal:  Indian J Pediatr       Date:  2005-11       Impact factor: 1.967

4.  HDL composition regulates displacement of cell surface-bound hepatic lipase.

Authors:  Naghmeh Rouhani; Elizabeth Young; Cynthia Chatterjee; Daniel L Sparks
Journal:  Lipids       Date:  2008-08-01       Impact factor: 1.880

5.  Genetic analysis of Indian subjects with clinical features of possible type IIa hypercholesterolemia.

Authors:  Altaf A Kondkar; Kappiareth G Nair; Tester F Ashavaid
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

6.  Polymorphisms in the hepatic lipase gene affect plasma HDL-cholesterol levels in a Turkish population.

Authors:  Ugur Hodoglugil; David W Williamson; Robert W Mahley
Journal:  J Lipid Res       Date:  2009-09-04       Impact factor: 5.922

7.  Glucose increases hepatic lipase expression in HepG2 liver cells through upregulation of upstream stimulatory factors 1 and 2.

Authors:  D van Deursen; H Jansen; A J M Verhoeven
Journal:  Diabetologia       Date:  2008-08-30       Impact factor: 10.122

8.  Genetic copy number variants in myocardial infarction patients with hyperlipidemia.

Authors:  Wei-Chung Shia; Tien-Hsiung Ku; Yu-Ming Tsao; Chien-Hsun Hsia; Yung-Ming Chang; Ching-Hui Huang; Yeh-Ching Chung; Shih-Lan Hsu; Kae-Woei Liang; Fang-Rong Hsu
Journal:  BMC Genomics       Date:  2011-11-30       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.